Search This Blog

Monday, May 4, 2026

Vertex Pharma beats Q1 expectations with revenue up 8% to $2.99B

maintains 2026 guidance at $12.95–$13.1B

https://finviz.com/quote?t=VRTX&p=d

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.